SOUTH PLAINFIELD, N.J. – PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have symptoms consistent with, or a diagnosis of, cerebral palsy (CP) with no evidence of brain injury. CP is a group of disorders that affect a person’s ability to...
research News
LACHEN, Switzerland — Octapharma announced today the publication of the results from the clinical study WIL-31, which investigated the efficacy and safety of prophylaxis with wilate®, a von Willebrand factor/factor VIII (VWF/FVIII) concentrate, in patients with all types of von Willebrand disease (VWD). The results have been published in the...
NEW YORK, NY & MIAMI, Florida – New research has found that genetic variants associated with Parkinson’s disease (PD) are more common than researchers previously believed. Investigators in the Parkinson’s Foundation-backed PD GENEration study – which reached its goal of 15,000 participants ahead of schedule this spring – found that...
Busan, South Korea – Amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder, is a significant global health issue, affecting the voluntary motor nervous system in affected individuals. It is further compounded by a lack of effective treatment options. This treatment gap highlights the need to identify risk factors, particularly modifiable ones,...
BUSAN, South Korea — Atopic dermatitis (or AD) is a heterogenous, inflammatory condition of the skin and is usually accompanied by itch, redness, and swelling. AD can have a significant impact on the patient’s quality of life. While several biologic treatment approaches have been proposed in the recent years for...
Tampere, Finland – Depression and cardiovascular disease (CVD) are serious concerns for public health. Approximately 280 million people worldwide have depression, while 620 million people have CVD. It has been known since the 1990s that the two diseases are somehow related. For example, people with depression run a greater risk...
Seattle, Washinton – Of the 38 million Americans who have diabetes at least 90% have Type 2, according to the Centers for Disease Control and Prevention. Type 2 diabetes occurs over time and is characterized by a loss of the cells in the pancreas that make the hormone insulin, which...
Miami, Florida – The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent. Over the last decade, options have evolved from double, to triple to quadruple combination...
London, UK – Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses. Published in the IEEE Transactions on Biomedical Engineering, the study presents a significant advancement in early cancer detection, thanks to...
London, UK – Research on thousands of proteins measured from a drop of blood demonstrates the ability of proteins to predict the onset of many diverse diseases. The research, published today (22 July 2024) in Nature Medicine, was carried out as part of an international research partnership between GSK, Queen...